Last updated 2026-07-23
Total raised
—
Last: Grant 2019-07
Stage
Pre-Funding
Founded
2011
Headcount
6
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences
Website ↗Registrar ID: 514549997 (Lipomedix Pharmaceuticals Ltd.)
About
LipoMedix is a development-stage privately held company focused on developing an innovative, safe, and effective cancer therapy based on liposome delivery. The company's lead product, Promitil® (PL-MLP), is a pegylated liposomal mitomycin-C prodrug designed for selective delivery of the therapeutic agent to cancer-affected tissues, aiming to overcome the toxicity associated with conventional mitomycin-C. LipoMedix is advancing the pharmaceutical and clinical development of this patented new chemical entity. LipoMedix is majority owned by Rafael Holdings, Inc..
Offices
Jerusalem, Israel · HQ / main office
Q&A
- What is LipoMedix's primary focus?
- LipoMedix is a development-stage company focused on innovative, safe, and effective cancer therapy based on liposome delivery.
- What is LipoMedix's lead product?
- LipoMedix's lead product is Promitil, which has demonstrated antitumor effects in tumor models.
- When was LipoMedix founded?
- LipoMedix was founded in June 2011.
- What is LipoMedix's current product stage?
- LipoMedix's product is in the clinical trial stage.
- Has LipoMedix received any funding?
- Yes, LipoMedix received a Grant round in July 2019 from the European Commission.
- Who are the founders of LipoMedix?
- The founders of LipoMedix are Al Gabizon, who serves as Founder & President, and Rami Kremien, a Co-founder.
- What is LipoMedix's primary sector classification?
- LipoMedix's primary sector is Health Tech & Life Sciences.
Team · 6
Alberto Gabizon
Founder · President & Chief Scientific Officer
Howard Jonas
Chairman of the Board
Patricia Ohana
VP Clinical Affairs
Sanjeev Luther
Executive Chairman of the Board
Miranda J. Toledano
Board Member
Praveen Tyle
Board Member
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 PatentsVerified
Tags
canceroncologybiopharmaceuticaldrug-deliverytargeted-therapychemotherapytherapeuticspharmaceuticalspharma-companies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | lipomedix.com |
|---|
Identifiers & details
| Legal name | Lipomedix Pharmaceuticals Ltd. |
|---|---|
| Founded | 2011-6 |
| Employees (exact) | 6 |
Acquisitions & public offerings
Acquired by 2018-06
Radar intelligence
Patents
| EPO | 4 |
|---|
Publications (Crossref)
| Works | 4 |
|---|
Web history (Wayback)
| Domain | lipomedix.com |
|---|
Certificate / subdomain footprint
| Subdomains | 2 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514549997 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2011-01-06 |
| Purpose | לעסוק בסוגי עיסוק שפורטו בתקנון |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2024 |
| Active charges / liens | 0 |
| Registry events | 0 |
| Registered address | הגן הטכנולוגי 0 ירושלים |